CA2373447A1 - Permeabilisation de biofilms - Google Patents

Permeabilisation de biofilms Download PDF

Info

Publication number
CA2373447A1
CA2373447A1 CA002373447A CA2373447A CA2373447A1 CA 2373447 A1 CA2373447 A1 CA 2373447A1 CA 002373447 A CA002373447 A CA 002373447A CA 2373447 A CA2373447 A CA 2373447A CA 2373447 A1 CA2373447 A1 CA 2373447A1
Authority
CA
Canada
Prior art keywords
biofilm
target material
stress
compound
biofilms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002373447A
Other languages
English (en)
Inventor
Nikolaos S. Soukos
Shun Lee
Apostolos G. Doukas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2373447A1 publication Critical patent/CA2373447A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Anesthesiology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des procédés de perméabilisation de biofilms faisant appel à des ondes de contrainte et consistant à appliquer une ou plusieurs ondes de contrainte sur un biofilm, par exemple sur une surface d'un dispositif ou d'un produit alimentaire, ou encore sur une surface tissulaire d'un patient, puis à induire des ondes de contrainte pour provoquer des augmentations transitoires de la perméabilité du biofilm. Cette amélioration de la perméabilité facilite la distribution de composés, notamment des agents antimicrobiens ou thérapeutiques dans et à travers le biofilm.
CA002373447A 1999-05-12 2000-05-12 Permeabilisation de biofilms Abandoned CA2373447A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13373099P 1999-05-12 1999-05-12
US60/133,730 1999-05-12
PCT/US2000/013231 WO2000067917A1 (fr) 1999-05-12 2000-05-12 Permeabilisation de biofilms

Publications (1)

Publication Number Publication Date
CA2373447A1 true CA2373447A1 (fr) 2000-11-16

Family

ID=22460051

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002373447A Abandoned CA2373447A1 (fr) 1999-05-12 2000-05-12 Permeabilisation de biofilms

Country Status (4)

Country Link
EP (1) EP1210182A1 (fr)
JP (1) JP2003534235A (fr)
CA (1) CA2373447A1 (fr)
WO (1) WO2000067917A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
US6576226B1 (en) * 2000-11-17 2003-06-10 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
ES2441408T3 (es) 2003-03-27 2014-02-04 The General Hospital Corporation Aparato para tratamiento dermatológico y rejuvenecimiento cutáneo fraccional
US7413572B2 (en) 2004-06-14 2008-08-19 Reliant Technologies, Inc. Adaptive control of optical pulses for laser medicine
JP4500206B2 (ja) * 2005-05-09 2010-07-14 株式会社三栄水栓製作所 バイオフィルム評価方法
ES2714008T3 (es) 2007-07-12 2019-05-24 Oral Health Australia Pty Ltd Tratamiento de biopelícula
NZ598834A (en) 2008-08-29 2013-06-28 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of P. gingivalis infection
US8679103B2 (en) 2008-12-22 2014-03-25 Valam Corporation Two step mammalian biofilm treatment processes and systems
CN103417546B (zh) * 2013-08-19 2016-01-27 中国人民解放军军事医学科学院基础医学研究所 亚甲蓝的一种麻醉后促清醒的用途
KR102087187B1 (ko) * 2013-12-03 2020-03-11 (주)아모레퍼시픽 피부 개선용 키트

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5421816A (en) * 1992-10-14 1995-06-06 Endodermic Medical Technologies Company Ultrasonic transdermal drug delivery system
US5458140A (en) * 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US6041252A (en) * 1995-06-07 2000-03-21 Ichor Medical Systems Inc. Drug delivery system and method
US5618275A (en) * 1995-10-27 1997-04-08 Sonex International Corporation Ultrasonic method and apparatus for cosmetic and dermatological applications
US6009346A (en) * 1998-01-02 1999-12-28 Electromagnetic Bracing Systems, Inc. Automated transdermal drug delivery system
US6030374A (en) * 1998-05-29 2000-02-29 Mcdaniel; David H. Ultrasound enhancement of percutaneous drug absorption

Also Published As

Publication number Publication date
JP2003534235A (ja) 2003-11-18
WO2000067917A1 (fr) 2000-11-16
EP1210182A1 (fr) 2002-06-05

Similar Documents

Publication Publication Date Title
Al Shahrani et al. Enhanced removal of Enterococcus faecalis biofilms in the root canal using sodium hypochlorite plus photon-induced photoacoustic streaming: an in vitro study
Grzech-Leśniak et al. Laser reduction of specific microorganisms in the periodontal pocket using Er: YAG and Nd: YAG lasers: a randomized controlled clinical study
GUTKNECHT et al. Diode laser radiation and its bactericidal effect in root canal wall dentin
Sarda et al. Antimicrobial efficacy of photodynamic therapy, diode laser, and sodium hypochlorite and their combinations on endodontic pathogens
Bevilacqua et al. The impact of photodynamic therapy on the viability of Streptococcus mutans in a planktonic culture
Pedullà et al. Decontamination efficacy of photon‐initiated photoacoustic streaming (PIPS) of irrigants using low‐energy laser settings: an ex vivo study
Lee et al. Photo‐activated disinfection of the root canal: a new role for lasers in endodontics
JP2008507327A (ja) 歯科的用途のための音響光力学的治療
Zand et al. Antimicrobial efficacy of photodynamic therapy and sodium hypochlorite on monoculture biofilms of Enterococcus faecalis at different stages of development
US20050059731A1 (en) Erythrosin-based antimicrobial photodynamic therapy compound and its use
CA2373447A1 (fr) Permeabilisation de biofilms
US20090054881A1 (en) Mammalian biofilm treatment processes and instruments
CA2272647A1 (fr) Apport de composes au moyen de phenomenes transitoires impulsionnels
Liu et al. Bacterial-killing effect of atmospheric pressure non-equilibrium plasma jet and oral mucosa response
EP1701726B1 (fr) Composition pour utilisation dans la thérapie photodynamique
Xu et al. Minimization of treatment time for in vitro 1.1 MHz destruction of Pseudomonas aeruginosa biofilms by high-intensity focused ultrasound
Carvalho et al. Analysis of Aloe vera cytotoxicity and genotoxicity associated with endodontic medication and laser photobiomodulation
Rödig et al. Effect of fiber insertion depth on antibacterial efficacy of photodynamic therapy against Enterococcus faecalis in rootcanals
Tokuc et al. Bactericidal effect of 2780 nm Er, Cr: YSGG laser combined with 940 nm diode laser in Enterococcus faecalis elimination: a comparative study
Miranda et al. Novel technologies to improve the treatment of endodontic microbial infections: Inputs from a drug delivery perspective
US7332200B1 (en) Permeabilizing biofilms
Vezzani et al. Disinfection of root canals using Er: YAG laser at different frequencies
Ogura et al. Photomechanical wave-assisted molecular delivery in oral biofilms
Wang et al. The penetration effect of HMME-mediated low-frequency and low-intensity ultrasound against the Staphylococcus aureus bacterial biofilm
Prabakharan et al. Proteus mirabilis viability after lithotripsy of struvite calculi

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead